Renaissance Technologies’s Entrada Therapeutics TRDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.55M | Buy |
379,500
+51,015
| +16% | +$343K | ﹤0.01% | 1961 |
|
2025
Q1 | $2.97M | Buy |
328,485
+162,285
| +98% | +$1.47M | ﹤0.01% | 1751 |
|
2024
Q4 | $2.87M | Buy |
166,200
+72,400
| +77% | +$1.25M | ﹤0.01% | 1807 |
|
2024
Q3 | $1.5M | Buy |
93,800
+49,200
| +110% | +$786K | ﹤0.01% | 2202 |
|
2024
Q2 | $636K | Buy |
+44,600
| New | +$636K | ﹤0.01% | 2583 |
|
2022
Q2 | – | Sell |
-11,800
| Closed | -$111K | – | 4579 |
|
2022
Q1 | $111K | Sell |
11,800
-1,773
| -13% | -$16.7K | ﹤0.01% | 3774 |
|
2021
Q4 | $232K | Buy |
+13,573
| New | +$232K | ﹤0.01% | 3455 |
|